Health Care Professionals Important Safety Information. Click or see below for Indication & Important Safety Information, or visit bit.ly/inpefahcp Prescribing Information: bit.ly/43R6wxz Patient Medication Guide: bit.ly/43vpius
INPEFA® (sotagliflozin) HCP
Pharmaceutical Manufacturing
Learn more at www.INPEFAHCP.com. For US health care professionals only.
About us
This page is for US Healthcare Professionals only. Before posting, please make sure to read our community rules. We are open to conversation but reserve the right to delete comments and block users from our page if they violate any of these rules: • Do not mention specific treatments, side effects, or safety information on this page. These posts will be deleted, but we may follow up with you privately for more information. • Do not give medical advice, ask for medical advice, or use this page as a source of medical advice. Medical advice includes any advice regarding issues with mental health. • Opinions or endorsements expressed by third parties are not necessarily shared by Lexicon. • Please be courteous and respectful of others. We do not tolerate using offensive, discriminatory, or malicious language. • Do not disclose personal, confidential, non-public, or otherwise sensitive information about you or anyone else. This includes, but is not limited to, contact information, health-related information, or content that infringes on the rights or privacy of others who have not consented to that information or content being shared. • In order to maintain the integrity of ongoing and past trials, all comments containing details about personal or second-hand experiences in clinical trials will be removed from this page. Thank you for reading and following our community rules. We will try our best to respond to your comments promptly. This page is run by Lexicon Pharmaceuticals. INPEFA® is a trademark of Lexicon Pharmaceuticals, Inc. ©2023, LEXICON PHARMACEUTICALS, INC. ALL RIGHTS RESERVED job-000575 01/24 Privacy Policy: https://www.lexpharma.com/privacy-policy Terms of Use: https://www.lexpharma.com/terms-of-use Important Safety Information is available at www.INPEFAhcp.com Please see full Prescribing Information https://bit.ly/43R6wxz and Patient Medication Guide https://bit.ly/43vpius
- Website
-
https://www.inpefahcp.com
External link for INPEFA® (sotagliflozin) HCP
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
Updates
-
Thank you to everyone who connected with us at this year’s San Diego HF Symposium. We invite you to discover the efficacy of INPEFA® (sotagliflozin) in the SCORED trial: bit.ly/SCORED #Sotagliflozin #INPEFA #GDMT #SDHF2024 #SCORED
-
Treat your patients with the proven efficacy of INPEFA® (sotagliflozin). You can connect with us near the entrance to the main session at the San Diego HF Symposium to discover more about what 33- 50-4 could mean for your patients – or visit bit.ly/soloist-whf-trial. #Sotagliflozin #INPEFA #SOLOISTWHFTrial #SDHF2024
-
Join us TODAY at the San Diego HF Symposium Breakfast Session to learn more about what INPEFA® (sotagliflozin) can do for your patients. The event starts at 8 AM PST in the Scripps Ballroom and will feature key experts Drs. Budoff and Greenberg. You can also connect with us near the entrance to the main session throughout today. Visit bit.ly/inpefahcp for more information. #Sotagliflozin #INPEFA #SDHF2024
-
We’re pleased to be at the 30th Annual San Diego HF Symposium in La Jolla, CA! Join us at the Breakfast Session TOMORROW in the Scripps Ballroom to hear from key experts Drs. Budoff and Greenberg. You can also visit us near the entrance to the main session to learn about INPEFA® (sotagliflozin): bit.ly/inpefahcp #Sotagliflozin #INPEFA #SDHF2024
-
We’re at the 2024 San Diego HF Symposium! Connect with us near the entrance to the main session. We encourage you to attend the Saturday Breakfast Session to learn about INPEFA® (sotagliflozin) – July 20, 8 AM PST in the Scripps Ballroom. View data: bit.ly/inpefahcp #Sotagliflozin #INPEFA #SDHF2024
-
-
ASPC 2024 kicks off at the Hyatt Regency Salt Lake City in just two weeks, August 2-4. We look forward to connecting with you about INPEFA® (sotagliflozin). Make sure to catch our expert theater on “Harnessing SGLT Inhibition in the Treatment of HF” in the Alta conference room, 3rd level – August 3 at 12 PM MST. Discover more: bit.ly/soloist-whf-trial #INPEFA #Sotagliflozin #ASPC2024 #SoloistWHFTrial
-
Treat patients with the proven efficacy of INPEFA® (sotagliflozin). Discover the SCORED trial results for patients with type 2 diabetes, chronic kidney disease and additional cardiovascular risk factors: bit.ly/SCORED #Sotagliflozin #INPEFA #SCOREDTrial #SDHF2024
-
We'll be heading to Hilton La Jolla Torrey Pines in La Jolla, CA next week for the 30th Annual 2024 San Diego HF Symposium. Join us at the Breakfast Session to hear from key experts Drs. Budoff and Greenberg on “Harnessing SGLT Inhibition in the Treatment of HF” – Saturday, July 20 at 8 AM PST in the Scripps Ballroom. You can also learn about INPEFA® (sotagliflozin) near the entrance to the main session: bit.ly/inpefahcp #Sotagliflozin #INPEFA #SDHF2024
-
What is worsening heart failure (WHF)? Learn more about WHF and how prescribing INPEFA® can help your patients: bit.ly/inpefahcp #Sotagliflozin #InpefaFDAApproved